CARCINOMA, TRANSITIONAL CELL

Clinical trials for CARCINOMA, TRANSITIONAL CELL explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, TRANSITIONAL CELL trials appear

Sign up with your email to follow new studies for CARCINOMA, TRANSITIONAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New Triple-Threat treatment enters final testing for tough bladder cancers

Disease control Recruiting now

This study is testing whether adding a new drug called vepugratinib to two existing cancer drugs works better for people with advanced bladder cancer that has spread and has a specific genetic change (FGFR3). About 450 adults who haven't had treatment for their advanced cancer wi…

Matched conditions: CARCINOMA, TRANSITIONAL CELL

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Mar 12, 2026 13:50 UTC

CARCINOMA, TRANSITIONAL CELL

Get alerted when new CARCINOMA, TRANSITIONAL CELL trials appear

New Triple-Threat treatment enters final testing for tough bladder cancers